Contribute Try STAT+ Today

WASHINGTON — President Biden is set to freeze a spate of last-minute Trump administration regulations — including, most likely, a change to the FDA’s authority over medical devices and a tweak to certain Medicare drug coverage rules issued only Tuesday.

Biden’s chief of staff Ron Klain issued a “regulatory freeze memo” Wednesday. The memo directs all agencies to consult with the White House before moving forward with implementing any so-called midnight guidances or regulations, a term that typically refers to policies unveiled during the final months of an administration. The freeze will apply to all regulations and guidances that either haven’t been published in the Federal Register or haven’t yet been enacted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.